Global Endobronchial Valves Market Size Study, by Product Type (Duckbill-Shaped, Umbrella-Shaped), by End User (Hospitals, Clinical Research Center, Ambulatory Surgery Center, Others) and Regional Forecasts 2022-2032

Global Endobronchial Valves Market Size Study, by Product Type (Duckbill-Shaped, Umbrella-Shaped), by End User (Hospitals, Clinical Research Center, Ambulatory Surgery Center, Others) and Regional Forecasts 2022-2032

Global Endobronchial Valves Market is valued approximately at USD 171.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2032. Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive pulmonary disease (COPD). These small, one-way valves are implanted in the airways of the lungs using a minimally invasive bronchoscopy procedure. Once in place, they allow air to exit the over-inflated, diseased parts of the lungs but prevent air from entering these areas. This process reduces lung hyperinflation and redirects airflow to healthier parts of the lung, thereby improving breathing efficiency. By relieving pressure and reducing the volume of the diseased lung sections, endobronchial valves help enhance overall lung function, alleviate symptoms like shortness of breath, and improve the patient's quality of life. The procedure is generally considered for patients who are not candidates for more invasive surgical interventions like lung volume reduction surgery or lung transplantation. The increasing prevalence of lung-related health issues, notably chronic obstructive pulmonary disease (COPD), is driving the demand for innovative medical devices like endobronchial valves. COPD is a leading cause of mortality, claiming approximately 3 million lives annually, according to the American Journal of Respiratory and Critical Care Medicine. This alarming statistic underscores the need for effective treatment options, including minimally invasive procedures facilitated by endobronchial valves, which are increasingly preferred over traditional open surgeries due to reduced trauma.

The Endobronchial Valves Market is also bolstered by the significant number of clinical trials focused on COPD, as reported by the WHO International Clinical Trials Registry Platform, with over 600 ongoing studies. This active research landscape highlights the growing interest and investment in discovering new treatment methodologies for COPD, which is expected to propel the endobronchial valves market forward. For instance, a study published in MDPI in November 2022 emphasized the advancements in bronchoscopic management for COPD, reflecting the ongoing efforts to enhance therapeutic options in this field. Moreover, rising awareness about bronchoscopic lung volume reduction as a viable treatment for lung-related health issues is further driving the market. However, the high cost associated with bronchoscopic valves, driven by the limited number of market players, poses a challenge to broader market expansion.



The key regions considered for the Global Endobronchial Valves Market study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa, North America held the largest market share in 2023, driven by the high prevalence of COPD and robust healthcare infrastructure. The region's focus on clinical trials and innovative treatments, alongside FDA approvals for devices like Zephyr and Spiration valves, reinforces its market dominance. The Asia Pacific region is expected to grow rapidly due to the aging population and increasing incidence of lung diseases, driven by factors such as air pollution and occupational hazards.

Major market players included in this report are:

Pulmonx Corporation

Olympus Corporation

Spiration Inc. (a subsidiary of Olympus)

Boston Scientific Corporation

Medtronic plc

Merit Medical Systems, Inc.

Broncus Medical Inc.

ALung Technologies, Inc.

BTG International Ltd. (a subsidiary of Boston Scientific)

PneumRx, Inc. (a BTG company)

Innovative Airway Solutions

IntraPace, Inc.

Uptake Medical Corporation

Novatech SA

TARIS Biomedical LLC

The detailed segments and sub-segment of the market are explained below:

By Product Type:

Duckbill-Shaped

Umbrella-Shaped

By End User:

Hospitals

Clinical Research Center

Ambulatory Surgery Center

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.